|
STAM2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.57749999951662E-07 |
| Normal-vs-Stage3 |
2.20334861467109E-12 |
| Normal-vs-Stage4 |
9.13189968088091E-10 |
| Stage1-vs-Stage2 |
8.619800E-01 |
| Stage1-vs-Stage3 |
9.161000E-01 |
| Stage1-vs-Stage4 |
8.486200E-01 |
| Stage2-vs-Stage3 |
9.339600E-01 |
| Stage2-vs-Stage4 |
7.484400E-01 |
| Stage3-vs-Stage4 |
7.537600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
5.82744963395498E-12 |
| Normal-vs-Asian |
1.33599999996292E-06 |
| Caucasian-vs-AfricanAmerican |
2.937800E-01 |
| Caucasian-vs-Asian |
8.762000E-01 |
| AfricanAmerican-vs-Asian |
8.444000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
2.30469976436609E-10 |
| Male-vs-Female |
1.558870E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.16253706450698E-14 |
| Normal-vs-Extreme_Weight |
<1E-12 |
| Normal-vs-Obese |
1.65767399806782E-12 |
| Normal-vs-Extreme_Obese |
7.118900E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.134400E-01 |
| Normal_Weight-vs-Obese |
2.582400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.368000E-01 |
| Extreme_Weight-vs-Obese |
3.089700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.685600E-01 |
| Obese-vs-Extreme_Obese |
8.471800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.986800E-04 |
| Normal-vs-Age(41-60Yrs) |
3.5527136788005E-15 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
6.31390495442474E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.470400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.685600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.882000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.724200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.893500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.644400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.6251444634463E-12 |
| Normal-VS-KIRP CIMP |
3.91529999976825E-07 |
| Normal-VS-Unclassified PRCC |
7.92970000000892E-05 |
| Type1 PRCC-VS-Type2 PRCC |
8.921600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.366600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.095500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.798000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.396000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.817000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.64035451888367E-12 |
| Normal-vs-N1 |
3.73350017568441E-10 |
| Normal-vs-N2 |
1.99430000002998E-06 |
| N0-vs-N1 |
3.804000E-01 |
| N0-vs-N2 |
7.327600E-01 |
| N1-vs-N2 |
3.901400E-01 |
|
|
